News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Conditas Group Signs Exclusive US Business Development Deal for Medicinal Chemistry and Drug Discovery Services with Melbourne and Shanghai Based Synthesis Med Chem USA for Medicinal Chemistry and Drug Discovery Services


11/30/2011 9:14:43 AM

BOSTON--(BUSINESS WIRE)--Conditas Biotechnology Group, LLC, a boutique firm that represents on- and off-shore Contract Research Organizations (CROs) and service providers, connecting them to customers in academia and the biotechnology and pharmaceutical industries, has signed an exclusive agreement with SYN|thesis med chem Pty Ltd.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES